TRAVERE THERAPEUTICS, INC. Cash Acquired from Acquisition
TRAVERE THERAPEUTICS, INC. (TVTX) reported Cash Acquired from Acquisition of -$29.15 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow
us-gaap:CashAcquiredFromAcquisition · last filed 2015-03-11
- TRAVERE THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2014-06-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2014-03-31 was -$29.15M.
- TRAVERE THERAPEUTICS, INC. cash acquired from acquisition for fiscal 2012 was $3.72K.
| Period end | Cash Acquired from Acquisition 3 month | Cash Acquired from Acquisition 6 month | Cash Acquired from Acquisition 12 month |
|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$29.15M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$29.15M 10-Q · filed 2014-05-15 | ||
| 2012-12-31 | $3.72K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |